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Abstract 
Background: Pathogenic bacteria contribute to various globally important diseases, killing millions of people each 
year. Various fields of medicine currently benefit from or may potentially benefit from the use of nanotechnology 
applications, in which there is growing interest. Disease-related biomarkers can be rapidly and directly detected by 
nanostructures, such as nanowires, nanotubes, nanoparticles, cantilevers, microarrays, and nanoarrays, as part of an 
accurate process characterized by lower sample consumption and considerably higher sensitivity. There is a need for 
accurate techniques for pathogenic bacteria identification and detection to allow the prevention and management 
of pathogenic diseases and to assure food safety.
Conclusion: The focus of this review is on the current nanoparticle-based techniques for pathogenic bacterial identi-
fication and detection using these applications.
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Background
Pathogenic bacteria contribute to various globally impor-
tant diseases, killing millions of people each year [1]. The 
amount of pathogen required to cause infection in the 
host does not need to be high to lead to life-threatening 
conditions such as sepsis, which is a major public health 
concern [2]. The incidence of sepsis is underestimated, 
and common risk factors include being of a very young 
or old age. A drawback in the management of sepsis is the 
length of time required to develop cultures for diagno-
sis. A severe blood infection, sepsis requires the identi-
fication of the responsible organism (bacterium, fungus, 
virus, or parasite). When bacteria are present, a more 
thorough analysis involves extensive cell cultures. Sepsis 
is only treated after identification of the microorganism 
and assessment of its antibiotic resistance [3]. Bacte-
rial counts below 10 colony-forming units per milliliter 
(CFU/mL) of blood are not sufficient for identifying bac-
teria using non-DNA based techniques; only additional 
bacterial cultures can provide the amount necessary for 
accurate diagnosis [4].
Various fields of medicine currently benefit from or 
may potentially benefit from the use of nanotechnology 
applications, in which there is growing interest [5–8]. The 
use of nanotechnology in medicine, especially in drug 
delivery, may revolutionize this domain and is expected 
to spread rapidly in coming years [9–16]. Various other 
applications are based on genetic engineering advances 
and improved imaging technologies, such as in  vivo 
imaging, in vitro diagnostics (which can detect diseases, 
conditions, or infections), multiple types of therapies, 
biomaterials (which interact with biological systems for 
therapeutic or diagnostic purposes), and tissue engineer-
ing (which combines scaffolds, cells, and biologically 
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Disease-related biomarkers can be rapidly and directly 
detected by nanostructures, such as nanowires, nano-
tubes, nanoparticles, cantilevers, microarrays, and 
nanoarrays, as part of an accurate process characterized 
by lower sample consumption and considerably higher 
sensitivity [25–35]. Not only does nanotechnology enable 
the early identification of viruses, bacteria, and circulat-
ing tumor cells, it also has proven potential for single-cell 
analysis [36].
The use of carbon nanotubes, magnetic nanoparticles, 
and quantum dot-based nanoprobes for in vivo targeted 
imaging might pave the way for the rapid, minimally inva-
sive, and more rigorous diagnosis of diseases like cancer, 
which could be detected at an early stage and monitored 
throughout its course [37–39]. Moreover, the confirma-
tion of in  vivo therapeutic efficacy, the assessment of 
nanocarrier biodistribution, the ability to pinpoint the 
exact location of the tumor and the surrounding healthy 
tissue, and the possibility of lymphatic mapping and sen-
tinel node analysis are other benefits of nanotechnology-
based applications [40–44].
Nanomaterials have unique physical and chemi-
cal properties (ultra-small size, large surface-area-to-
mass ratio, high reactivity) that are different from bulk 
materials of the same composition and that help them 
overcome some of the limitations of traditional thera-
peutic and diagnostic agents [35, 45–48]. Synthesized 
hafnium oxide-gold core–shell nanoparticles showed 
enhanced plasmon absorption bands, while synthesized 
gold nanoshells, gold nanorods, carbon nanotubes and 
magnetic nanoparticles have been shown to be efficient 
in nanoparticle-induced magnetic hyperthermia treat-
ments, causing cancerous cells to undergo apoptosis 
in direct response to applied heat. There are also data 
demonstrating that nanocrystalline silver dressings may 
reduce bacterial levels, decrease the chronic inflamma-
tory response, and promote wound healing [17, 18, 49, 
50]. There is a need for accurate techniques for patho-
genic bacteria identification and detection to allow the 
prevention and management of pathogenic diseases and 
to assure food safety.
Conventional techniques employed for detecting 
microorganisms, such as microbial cultures and bacterial 
growth, are lengthy and difficult to perform, requiring 
6–24 h for the growth process [51], followed by 1–3 days 
for the morphological and biochemical characterization 
of bacterial isolates.
The size and properties of nanoparticles make them 
excellent platforms for the detection and identification 
of pathogens in native biological samples [16, 28, 52–54]. 
Magnetic nanoparticles are used for detecting bacteria, 
which can be further studied using nuclear magnetic res-
onance imaging [55]. Therefore, the focus of this review 
is on the current nanoparticle-based techniques for path-
ogenic bacterial identification and detection using these 
applications (Table 1).
Bacterial detection using gold nanoparticles
Gold nanoparticles (AuNP) have been used over a wide 
range of biological applications due to their characteris-
tics such as the surface Plasmon band localization in the 
visible spectrum, ease of synthesis, various functionaliza-
tion capabilities [67–70].
AuNP fluorescent molecular beacons were prepared 
for synthetic DNA and bacterial 16S rRNA detection of 
Escherichia coli (DH5α) in cell cultures [63]. AuNP–DNA 
molecular beacon conjugates determined a sensitivity 
enhancement by three orders of magnitude, allowing for 
the detection of E. coli within 1  h (100  CFU/mL, 1000 
times more sensitive than molecular beacons alone). In 
another instance, dipicolinic acid, a unique biomarker 
of bacterial spores, was detected by using  Tb3+ and  Eu3+ 
chelated AuNPs as nanosensors [71]. Also, Jin et al. [72] 
used lanthanide-doped upconversion nanoparticles func-
tionalized with complementary DNA in conjunction with 
aptamer functionalized gold nanoparticles for a detec-
tion platform based on fluorescence resonance energy 
transfer in order to detect E. coli in real food and water 
samples.
The interaction of AuNPs with cysteine was tested 
by Raj et  al. [59] for the detection of E. coli. The bind-
ing affinity of E. coli 0157:H7 to H2 receptors on the 
surface of cysteine-modified AuNPs was demonstrated 
by the electrostatic adhesion between the positively 
charged cysteine and the negatively charged lipopolysac-
charides on the bacterial outer membrane. The negative 
charge enabled E. coli stabilization. The cross-linking of 
cysteine-capped AuNPs was performed in the presence 
of a defined number of bacteria with a clear red-to-blue 
shift in sample color and a highly sensitive naked-eye 
detection of bacteria. Urine samples (3 ×  104  cells/mL) 
were concentrated using cysteine-capped AuNPs for fur-
ther clinical use. There was a maximum shift of 10  nm, 
consistent with values obtained in conventional aqueous 
solutions, demonstrating that the new method can be 
used to accurately detect and assess E. coli 0157:H7 bac-
teria. A novel aptasensor for the colorimetric detection 
of Salmonella typhimurium based colour change effect of 
gold nanoparticles was developed by Ma et al. [73]. Gold 
nanoparticles were functionalized with aptamers capa-
ble recognize S. typhimurium which acted as stabilizers 
for the GNPs even at high concentrations of NaCl. In the 
presence of the S. typhimurium bacteria the aptamers 
present on the nanoparticle surface bind to the bacteria 
which results in the aggregation of the GNPs, thus a vis-
ible colour change. The limit of detection for this method 
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was as low as 56 CFU/mL. Another study that utilizes the 
antibody functionalized AuNPs for detection of Lactoba-
cillus spp. and Staphylococcus aureus was presented by 
Verdoot et al. [74]. In this case the local surface plasmon 
resonance (LSPR) band of the AuNPs is monitored by 
means of UV–Vis spectroscopy.
Polyethylenimine (PEI)-capped AuNPs were developed 
as another biosensor for the rapid detection of bacteria 
[75]. The colorimetric assay demonstrated the high bind-
ing affinity of positively charged PEI-AuNPs to bacteria 
with a negative charge. There was a strong interaction 
between PEI-AuNPs and β-galactosidase on the bacte-
rial surface. The method was conceived to be simple and 
quick, and allowed a detection limit close to 10 CFU/mL. 
The aim was to ensure that the positively charged AuNPs 
selectively bind to the negatively charged bacterial cell 
wall in the presence of teichoic acids in Gram-positive 
bacteria or of lipopolysaccharides in Gram-negative 
bacteria. There were competitive interactions between 
PEI-AuNPs and the bacterial or enzyme surfaces when 
β-galactosidase was present.
Bimetallic silver–gold clusters were obtained through 
synthesis of gold nanoparticle (AuNP) seeds that cata-
lyzed the reduction of gold salts, enhancing the nano-
particles and supplying more gold nuclei with the 
subsequent addition of silver atoms on AuNPs [60]. The 
synergistic enhancement effects of a dual catalyst include 
improved optical intensity that enhances color percep-
tion and sensitivity (Fig. 1).
Dual nanocatalysis was employed for the detection of 
Campylobacter jejuni, a Gram-negative spiral-shaped 
bacteria responsible for campylobacteriosis, one of the 
most common bacterial infections in humans. The model 
immunoassay was performed on a glass slide, displaying 
rapid and selective detection of C. jejuni with at least four 
orders of magnitude greater linear dynamic range and a 
limit of detection of 10 CFU/mL [60].
Au–Ag core–shell nanoparticles were used by Ding 
et  al. [76] to form aggregates for simultaneous bacterial 
imaging and synergistic antibacterial activity. The prin-
ciple of this approach is based on the fact that the posi-
tively charged Au–Ag core–shell NPs form aggregates on 
the negatively charged bacterial surface of S. aureus with 
an enhanced two-photon photoluminescence effect.
Gold-coated magnetic nanoparticles were synthesized 
employing hydroxylamine seeding based on a sonochem-
ical method [62]. The nanoparticles had the same size 
and shape, were stable, and possessed excellent magnetic 
responsivity and strong surface-enhanced Raman spec-
troscopy (SERS) activity.
A highly sensitive sandwich-structured SERS plat-
form was developed for the detection of S. aureus. A 
SERS assay and a SERS tag enabled the bio-separation 
and detection of bacteria. There were strong coupling 
Fig. 1 Overall scheme illustrating the procedure of the dual-enhanced scanometric assay for the detection of bacteria (Reprinted with permission 
from [60])
Page 5 of 14Mocan et al. J Nanobiotechnol  (2017) 15:25 
interactions between AuMNPs and the bacterial sam-
ples, with multiple hotspots and an increase in the SERS 
signal. Individual and inter-particle magnetic hotspots 
identified an increase in the Raman signal of the bacterial 
samples and a subsequent higher sensitivity of bacterial 
detection. S. aureus was detected via the SERS method 
based on the sandwich-structured immunoassay, with a 
detection limit of 10 cells/mL (Fig. 2).
A label-free method for the quick and effective detec-
tion of bacteria was developed in another study using 
SERS, PEI-conjugated gold-coated magnetic micro-
spheres, and gold-shell-coated silver nanoparticles 
(AgNPs) [54]. The capture-enrichment-enhancement 
(CEE) three-step method employed the capture and 
enrichment properties of PEI-conjugated gold-coated 
magnetic microspheres and SERS enhancement 
properties, so that the bacteria could be detected within 
10 min. The synthesis of magnetic microspheres for the 
efficient capture and separation of bacteria and for use 
as SERS substrates for bacterial analysis, and that of con-
centrated gold-shell-coated AgNPs for their reinforcing 
efficiencies, was consistent with the method requests. 
There were strong electrostatic interactions between 
PEI containing a positive charge and bacterial cells with 
a negative charge, which allowed for rapid and efficient 
bacterial capture and enrichment. This method proved to 
be efficient when using the optimum incubation time and 
particle concentration, detecting E. coli and S. aureus at a 
minimum detectable level of 1000 CFU/mL.
The photoacoustic detection of bacteria demonstrated 
potential in the peripheral blood of mice and rats  (102 
bacteria every 15 min), also exhibiting a possible increase 
Fig. 2 a Schematic representation of the synthesis of gold-coated magnetic nanoparticles. b Schematic representation of the methods employed 
for the detection of bacteria using a SERS method (Reprinted with permission from [62]. Copyright 2016 American Chemical Society)
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[77]. The photoacoustic flow cytometry method was 
developed for in  vivo detection of single absorbing tar-
gets in circulation based on time-resolved monitor-
ing, with or without nanoparticles as photoacoustically 
detectable labels (Fig. 3). This was the first study to prove 
the potential of photoacoustic flow cytometry with tun-
able near-infrared (NIR) lasers for the real-time monitor-
ing of gold nanorods, S. aureus and E. coli labeled with 
carbon nanotubes, and Lymphazurin in the ear blood 
microvessels and mesenteric structures of mice and rats. 
This method allows detection of single circulating cells 
or bacteria in the entire circulation of mice during con-
tinuous photoacoustic monitoring of larger vessels every 
hour. The results indicated a clearance rate with ultra-
high sensitivity for a single bacterium (or cancer cell) in a 
background of  108 normal blood cells.
Bacterial detection using silver nanoparticles
Silver nanoparticles (AgNPs), due to their unique char-
acteristics, present a high interest for several applications 
in life sciences. For example, Raman-based detection of 
bacteria using protein-A-antibody-modified AgNPs was 
employed in a study conducted by Ghinwa et  al. [78]. 
Selectivity was achieved by incubating bacteria with ade-
quate polyclonal antibodies. The selectivity of bacteria 
with surface-enhanced Raman spectroscopy was superior 
to that of bulk Raman spectroscopy.
The surface charge of the cell wall was mostly respon-
sible for the Raman spectra of microorganisms upon 
in situ synthesis of AgNPs directly on the surface of bac-
teria [36] (Fig.  4). This method showed that the Raman 
signal of these bacteria was approximately 30 times 
higher than that obtained by mixing colloid and bacte-
rial suspensions. The total time to set up and complete 
the assay was only 10  min and the total volume of the 
reactants required to assess the bacteria was 1  mL. As 
Fig. 3 Photoacoustic in vivo detection of single absorbing targets in 
circulation (Reprinted with permission from [73])
Fig. 4 In situ synthesis of AgNPs on the surface of bacteria, showing the electrostatic attraction between the nanoparticles and their cellular targets 
following the addition of the reducing agent (Reprinted with permission from [36]. Copyright 2014 American Chemical Society)
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little as 3 μL of sample was enough to perform the SERS 
measurements. Moreover, this new approach described 
by the authors was able to differentiate between three 
E. coli strains and one Staphylococcus epidermidis strain 
by means of a hierarchy cluster analysis. SERS mapping 
detected 250 CFU/mL on hydrophobic glass slides.
Lectin-sensitized anisotropic AgNPs were prepared to 
detect various bacterial strains, both Gram-negative and 
Gram-positive [79]. Major changes in the optical prop-
erties of the nanoparticles were induced following their 
interactions with bacteria.
Individual bacteria were rapidly detected using anodic 
particle coulometry [61]. As their binding affinity is well-
known, citrate-capped AgNPs (9.4  ±  3.6  nm diameter) 
and E. coli demonstrated the detection of individual bac-
teria within 1 min in solution containing 0.3 pM E. coli 
cells. Due to factors such as the high surface function-
ality of bacteria, the affinity of AgNPs for bacteria, and 
the electrochemical properties of the nanoparticles, the 
charge of individual bacteria was twice as high as the 
noise level.
Sulfate-reducing bacteria were selectively detected in a 
new approach using the photocatalytic properties of zinc 
sulfide (ZnS) nanoparticles [80]. The synthesis of these 
nanoparticles was based on specific bacterial metabolism 
and they were employed as photocatalysts for the photo-
degradation of methylene blue. This process was influ-
enced by the baseline concentration of bacteria. There 
was a linear relationship between the photodegradation 
of methylene blue and bacterial concentration (1.0 × 103 
to 1.0 ×  108  CFU/mL). The new approach also showed 
good specificity for the detection of sulfate-reducing 
bacteria.
An assay based on surface-enhanced Raman spectros-
copy analysis and AgNPs was developed to detect indi-
vidual bacterial species on microarrays [81]. SERS-active 
AgNPs were synthesized directly onto the surface of bac-
terial cells, mainly E. coli, determining the high detec-
tion-sensitivity of these microorganisms on a microarray 
platform. This method also employed receptor-selective 
antibodies. There was a tenfold increase in the Raman 
signal of the novel nanocompound compared to the 
values obtained when simply combining bacteria with 
AgNPs. Laser excitation below 633 nm exhibited optimal 
SERS activity of bacteria@AgNPs, probably as a result of 
the surface plasmon interactions of aggregated AgNPs.
Bacterial separation/detection using magnetic 
nanoparticles
Nanoparticle-based platforms have been employed for 
the diagnosis of tuberculosis in order to achieve early 
detection for better infection control. Bacillus Calmette-
Guérin (BCG) was used as a surrogate for Mycobacterium 
tuberculosis, showing a remarkable detection speed and 
sensitivity. Twenty CFU/mL were detected in sputum in 
<30 min [82].
Fluorescent magnetic nanoparticles have been used 
for biomedical applications to achieve rapid, sensitive, 
and cheap detection of bloodstream infections. Vanco-
mycin-modified magnetic nanoparticles were used to 
generate multivalent interactions and to detect bacteria 
in blood samples [58]. The enrichment culture was fur-
ther subjected to fluorescent vancomycin staining and 
bacteria were detected within 2 h, showing a sensitivity of 
10 CFU/mL. The back titration method was used to con-
firm bacterial counts.
Other researchers have shown that the antibiotic van-
comycin modified with trans-cyclooctene (Vanc-TCO) 
binds to the cell wall of Gram-positive bacteria by form-
ing hydrogen bonds with the terminal d-alanyl-d-alanine 
(d-Ala-d-Ala) moieties of the N-acetylmuramic acid 
(NAM) and N-acetylglucosamine (NAG) peptide subu-
nits [83]. Magnetofluorescent nanoparticles attached to 
tetrazine (MFNP-Tz) were employed for bacterial labe-
ling using bioorthogonal chemistry. The results showed 
dose-dependent binding of Vanc-TCO to S. aureus, S. 
pneumoniae, S. epidermidis, and E. faecalis cell walls. 
Therefore, labeling of Gram-positive bacteria can be 
achieved using bioorthogonal magnetofluorescent 
nanoparticles, also enabling the optical and magnetic 
detection of bacteria (Fig.  5). There was concentration-
dependent binding of nanoparticles to bacteria, vary-
ing according to the type of bacteria and inhibited with 
unmodified antibiotics [83].
It was also demonstrated that the bioorthogonal labe-
ling of living bacteria using synthesized TCO derivatives 
of vancomycin resulted in enhanced antibacterial activity 
following incubation for 24  h. This phenomenon might 
be caused by interference with the peptidoglycan layer in 
the bacterial cell wall, which is formed from the alternat-
ing linear chains of NAG and NAM amino sugars. The 
permeability of Vanc-TCO into mammalian cell cultures 
might also enable the detection of intracellular bacteria, 
for example those within macrophages.
Bacterial detection based on multicolor upconver-
sion nanoparticles coupled with magnetic nanoparticles 
was employed using a multiplexed fluorescence reso-
nance energy transfer aptasensor (Fig.  6). The targeted 
bacteria were S. aureus, Vibrio parahaemolyticus, and 
S. typhimurium [66]. Bacterial detection was achieved 
using different rare-earth-doped upconversion nanopar-
ticle labels with independent emission peaks. Autofluo-
rescence of biomolecules was prevented using a 980 nm 
infrared diode laser. Efficient separation and concen-
tration of targets from interferences in the food matrix 
were accomplished by magnetic nanoparticles, with no 
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need to pretreat the samples. Additionally, this method 
resulted in stable and target-specific aptamers, superior 
to the susceptibility of traditional antibodies. The authors 
reported the benefits of a novel aptamer-based detection 
assay used as a stable bioassay platform that provides 
high sensitivity and specificity [66].
Applications based on fluorescent nanocrystal quantum 
dots were described for the detection of bacteria with flow 
cytometry and flow cytometric determination of magnetic 
nanoparticle collection and separation [84]. The authors 
employed quantum dot fluorescent labels for specific 
conjugates against Bacillus anthracis and Yersinia pestis, 
facilitating bacterial dissemination. Highly sensitive mul-
tiplex detection of the two types of bacteria was achieved 
 (103  bacteria/mL in the original sample). Fluorescence-
activated cell sorting (FACS) was used for sensitive and 
selective analysis and enumeration of viable bacteria in the 
sample. The authors also developed an assay for the collec-
tion of viable Gram-negative bacteria (Y. pestis). Magnetic 
nanoparticles enabled the immunomagnetic detection and 
separation of bacteria, with fast sorting at high/low bacte-
rial concentrations  (105 CFU/mL) [84].
A magnetic nanoparticle microarray was developed 
for the simultaneous and simple detection of foodborne 
pathogens [14]. DNA microarray analysis using multiplex 
polymerase chain reaction (PCR) and labeling based on 
magnetic nanoparticles was described by Song et al. for the 
simultaneous detection of four common foodborne patho-
gens, E. coli O157:H7, Salmonella enterica, Vibrio cholera, 
and C. jejuni. The process employs two-stage amplifiers to 
simultaneously intensify target genes. The hybridization of 
biotinylated single-stranded PCR products to microarray 
Fig. 5 a Representat ion of trans-cyclooctene (TCO) derivatives of daptomycin binding to Gram-positive bacteria. Ca2þ channels control the 
process of oligomerization and binding to the cell surface results in the format ion of pores in the peptidoglycan layer. b Dapt-TCO derivatives 
detected using high-performance liquid chromatography and elect rosprayionization mass spectrometry. c Fluorescence spectrometry of bacterial 
cells stained with various concent rations of Dapt-TCO and labeled with magnet of luorescent nanoparticles (data expressed as mean and standard 
deviation). d Bacteria tracking by magnetic resonance (data expressed as mean and standard error) (Reprinted with permission from [79]. Copyright 
2011 American Chemical Society)
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probes was followed by the addition of magnetic nano-
particles coated with streptavidin in order to visualize the 
results of the hybridization process. The assay proved effi-
cient and exhibited low detection limits (316  CFU/mL), 
suitable for diagnosing infectious diseases in the labora-
tory or as part of real-time observations.
Sequence-specific detection of individual DNA strands 
was achieved in an assay developed by Strelau et al. [85] 
using surface-enhanced Raman scattering and mag-
netic nanoparticles for enrichment of target molecules. 
Hybridization in solution was employed for rapid and 
efficient binding of longer DNA strands (PCR prod-
ucts). DNA strands were purified and amplified after 
they were separated using magnetic nanoparticles. The 
hybridization of a dye-modified, short synthetic single-
stranded DNA was performed upon binding of the target 
DNA, serving as a Raman label. Molecular binding was 
detected by SERS spectra. The method was first applied 
using short synthetic oligonucleotides to assess its speci-
ficity, and later used to detect PCR amplification prod-
ucts for specific identification of epizootic hemorrhagic 
disease viruses. The authors used PCR targets based on 
sequences of Mycoplasma mycoides subspecies mycoides 
Small Colony type, which causes contagious bovine pleu-
ropneumonia. Three different PCR products labeled 
with three different dyes were simultaneously detected 
to show the strong SERS multiplexing ability. The results 
indicated the likelihood of employing magnetic beads for 
Raman-based detection of PCR products amplified from 
the DNA of epizootic pathogens.
The synthesis of amino-functionalized silica-coated 
magnetic nanoparticles and PCR was used for the rapid 
detection of foodborne pathogens via DNA isolation 
from milk [55]. The rapid and sensitive detection of single 
or multiple target pathogens was achieved in combina-
tion with PCR identification. The method employed both 
Gram-negative (Salmonella enteritidis) and Gram-positive 
(Listeria monocytogenes) bacteria to contaminate raw milk 
samples, obtaining a detection limit comparable to that 
of the immunomagnetic separation-polymerase chain 
reaction (IMS-PCR) assay. The detection limit in artifi-
cially contaminated raw milk was 8 CFU/mL for S. ente-
ritidis and 13 CFU/mL for L. monocytogenes when using 
the simplex PCR assay, and 15 CFU/mL for S. enteritidis 
and 25  CFU/mL for L. monocytogenes when using the 
multiplex PCR assay. Listeria monocytogenes detection by 
employing magnetic nanoparticles (MNPs) and the NMR 
technique was proposed by Zhao et al. [86] Antibody func-
tionalized silica coated MNPs dispersed in solution were 
found to self-assemble on the surface of a bacterial tar-
get accompanied by the increase of the T2 value of water 
Fig. 6 Graphical representation of bacterial detection based on a multiplexed fluorescence resonance energy transfer aptasensor (Reprinted with 
permission from [66]. Copyright 2014 American Chemical Society)
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protons which is detected with the aid of nuclear magnetic 
resonance, with a total protocol time of 40 min.
In another study, pathogenic bacteria were detected 
using antibody-conjugated magnetic nanoparticles [87]. 
Following synthesis, nanoparticles were magnetically 
separated from the analyte and used to detect Salmonella 
in milk. The MNP-Salmonella complexes were redis-
persed in buffer and exposed to antibody-immobilized 
 TiO2 nanocrystals with increased light absorption near 
230  nm. Following magnetic separation, the UV–Vis 
absorption spectra were collected for the solutions con-
taining unbound TNs. Due to the inversely proportional 
relationship between light absorption intensity and the 
concentration of bacteria, there was high sensitivity for 
low concentrations of Salmonella. The results obtained 
a detection limit of Salmonella in milk samples of 
>100 CFU/mL.
The quick, easy, and inexpensive detection of Salmo-
nella in buffer solution or in a milk matrix was achieved 
in a study conducted by Joo et al. [56] based on magnetic 
nanoparticles and titania  (TiO2) nanocrystals by isolating 
cells using immunomagnetic separation alongside opti-
cal sensing. Quick detection of bacteria was enabled by 
magnetic nanoparticles under external magnetic fields. 
Titania nanocrystals were employed as optical nano-
probes for spectroscopy assessment, as they display bet-
ter spectral stability than AuNPs at a range of pH values, 
temperatures, and salt concentrations. The conjugation 
of antibodies to magnetic nanoparticles can selectively 
target bacteria after being separated from solution by the 
application of an external magnetic field. There was an 
increase in absorbance at 230 nm following the binding 
of antibody-conjugated titania nanocrystals to the MNP-
Salmonella complexes. The authors reported bacterial 
detection limits of >100 CFU/mL in milk (Fig. 7).
Synthesized core–shell gold-coated  Fe3O4 magnetic 
nanoparticles (AuMNPs) were characterized using SERS 
for simultaneous fast concentration and sensitive detec-
tion of bacteria [64]. The application of an external mag-
netic field resulted in effective condensation within 5 min 
using 10 µL of  105 CFU/mL bacteria and 3 µg/mL AuM-
NPs on a silicon surface. The concentration of bacteria in 
the dot area was 60 times greater than in the surround-
ing area. The bacteria were surrounded by homogeneous 
AuMNPs, which enabled their sensitive and reproduc-
ible detection by SERS. Three different strains of Gram-
negative bacteria could be distinctly discriminated when 
using the principle component analysis (PCA) technique. 
The authors indicated the potential use of quantum dot 
AuMNPs as highly sensitive SERS-active substrates with 
a detection limit that was better than 0.1  ppb for small 
molecules (for example, 4-mercaptopurine).
In another study, quaternized magnetic nanoparticles 
(q-MNP)–fluorescent polymer systems were employed 
in an assay to support bacterial identification and 
detection [88]. The authors showed that the kinetics of 
q-MNP-PFBT polymer conjugates suggests their use as 
competent sensors for detecting pathogens. The appli-
cation of linear discriminant analysis (LDA) allowed 
the successful classification of eight different bacterial 
species: Shewanella oneidensis, Vibrio fischeri, Micro-
coccus luteus, Edwardsiella tarda, and E. coli in Luria–
Bertani medium; Vibrio alginolyticus and Pseudomonas 
aeruginosa in tryptic soy broth; and Pichia pastoris in 
yeast extract peptone dextrose medium. The canonical 
discriminant analysis was quick, easy to perform, and 
inexpensive. The sensitivity of this approach might be 
suitable for the detection of pathogenic bacteria, pro-
teins, or DNA tests [88].
Bacterial detection using other types of nanoparticles
The capture and detection of E. coli was achieved 
with immuno-nanorice particles obtained by attach-
ing polyclonal antibodies to the surface of the nanorice 
(hybrid nanoparticles with plasmonic properties of 
both nanoshells and nanorods in a single structure). 
The attachment of specific anti-E. coli antibodies to 
the nanorice was aided by protein-A molecules. The 
new particles demonstrated their binding affinity for 
E. coli cells. Following the capture of bacterial cells, the 
immuno-nanorice-bacteria complex was separated from 
the aqueous solution using the magnetic properties of the 
nanorice. Ultraviolet resonance Raman (UVRR) spectros-
copy allowed the detection of single bacterial cells when 
analyzing the bacteria sorbed onto the immuno-nanorice, 
with the substrate increasing the Raman intensity by sev-
eral orders of magnitude [89]. In another instance, the 
differentiation between Gram+ and Gram− bacteria 
was achieved by using 3D bio-inorganic scaffold of Agna-
noplate aggregate–bacteria–Au@Ag vertical nanorod 
supercrystal coupled with SERS [90].
Another nanosystem for bacterial detection and inhi-
bition was designed using polyion complex (PIC) micel-
lar nanoparticles [91]. The binding of bacteria to the PIC 
nanosystem resulted in dissolution as a consequence of 
competitive binding of polycation blocks with negatively 
charged bacterial surfaces, followed by prominent fluo-
rescence employed as a real-time module for microbial 
detection. The use of fluorometric assays led to a detec-
tion limit of 5.5  ×  104  CFU/mL for suspensions of E. 
coli cells. The minimum inhibitory concentration of PIC 
micellar nanoparticles was 19.7  mg/mL, demonstrating 
their potential use as antibacterial agents and displaying 
significant antibacterial effects.
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Isothermal amplified detection of RNA was employed 
for the visual and sensitive detection of viable pathogenic 
bacteria based on a bioactive paper-based platform [92]. 
The results were transformed into a two-dimensional bar 
code for a more thorough analysis. The assay included 
quick and efficient RNA extraction, amplification, and 
visualization. Concentrations of viable L. monocytogenes 
exhibited a detection limit of 0.5  pg/μL genomic RNA 
with high specificity within 15  min. The assay can be 
employed for the specific detection of 20 CFU/mL of L. 
monocytogenes in milk and cheese samples. The authors 
demonstrated that due to its viability, this assay allows 
for the transmission, reception, and sharing of the results 
with remote examiners for further testing [92].
Vibrio parahaemolyticus and S. typhimurium were 
simultaneously detected as part of an approach using a 
dual fluorescence resonance energy transfer (FRET) sys-
tem from green-emitting quantum-dots (gQDs) and 
red-emitting quantum-dots (rQDs) and nanoparticles 
containing amorphous carbon [28]. The gQDs-aptamer 
conjugates were employed to detect V. parahaemolyticus, 
while the rQDs-aptamer conjugates detected S. typh-
imurium. There was considerable fluorescence quench-
ing between quantum dots and CNPs. There was also a 
linear relationship between quantum dot fluorescence 
emission and bacterial concentration, ranging from 50 to 
106 CFU/mL. This method identified V. parahaemolyti-
cus with detection limits of 25 CFU/mL, and S. typhimu-
rium with detection limits of 35 CFU/mL. Bacteria were 
detected in real food samples and the results were in 
agreement with those obtained by the conventional plate 
count method [28].
Bacterial detection based on the preparation of CdSe/
ZnS@SiO2 fluorescent nanoparticles was suggested 
in another study [65]. The bacterium employed in this 
review was S. typhimurium. The reverse micro-emul-
sion method was used for the preparation of quantum 
dot-doped silica nanoparticles. The conjugated nano-
composite was prepared based on a two-step procedure 
for cross-linking with glutaraldehyde. The intensity of 
fluorescent light was directly proportional to the con-
centration of bacteria (6.6 ×  102 to 6.6 ×  104 CFU/mL, 
Fig. 7 Representation of the method employed for the detection of pathogenic bacteria using magnetic nanoparticles and optical nanoprobes 
(Reprinted with permission from [56])
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equation I =  0.1331 log C −  0.2017,  R2 =  0.9974). The 
results showed a detection limit of 3.3 ×  102  CFU/mL. 
This assay might also be used to detect other types of 
bacteria.
Cadmium sulfide (CdS) nanoparticles were prepared 
as fluorescent sensors for detection of sulfate-reducing 
bacteria (SRB) [57]. The nanoparticles were analyzed by 
transmission electron microscopy, selected area electron 
diffraction (SAED), and fluorescence spectroscopy. The 
CdS nanoparticles demonstrated a linear response in SRB 
culture solution (1.0 × 102 to 1.0 × 107 CFU/mL). There 
was a direct relationship between bacterial concentration 
and the intensity of the spectra, with a greater detection 
of SRB at higher concentrations. Concentrations ranged 
from 1.0 × 102 to 1.0 × 107 CFU/mL. There was a regres-
sion slope of 104.23 and a correlation coefficient of 0.996 
(FI =  104.23 ×  logNSRB +  30.63). This newly developed 
method for the detection of SRB might replace biological 
recognition elements, as it is cheaper, less time-consum-
ing, and able to preserve specific recognition proper-
ties. In another study, cadmium tellurium quantum dots 
were proposed by Cihalova et  al. [93] for the detection 
of S. aureus, MRSA and K. pneumoniae. By preparing 
complementary oligonucleotides for the specific bacte-
rial genes (fnbA for S. aureus, mecA for MRSA and wcaG 
for K. pneumoniae) and labeling them for simultaneous 
detection the detection limit of the method was as low as 
 102 CFU/mL.
Conclusion
The present review aims to discuss the significance and 
current issues related to the detection of bacteria, dis-
cussing some of the most relevant nanoparticle-based 
assays for this process. We provide information regard-
ing the various methods employed for the detection of 
bacteria using vancomycin-, daptomycin-, and antibody-
modified nanoparticles, as well as details on the bio-
conjugation of different types of nanoparticles. The use 
of nanoparticle-based methods might lead to further 
advances in the development of highly sensitive and spe-
cific assays for bacterial detection.
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